CN112400995A - Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people - Google Patents
Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people Download PDFInfo
- Publication number
- CN112400995A CN112400995A CN201910781402.2A CN201910781402A CN112400995A CN 112400995 A CN112400995 A CN 112400995A CN 201910781402 A CN201910781402 A CN 201910781402A CN 112400995 A CN112400995 A CN 112400995A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- lactobacillus plantarum
- goat milk
- omega
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 56
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 41
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 27
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 27
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 9
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 8
- 241000186016 Bifidobacterium bifidum Species 0.000 claims abstract description 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims abstract description 7
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 7
- 239000003765 sweetening agent Substances 0.000 claims abstract description 7
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 5
- 235000021119 whey protein Nutrition 0.000 claims abstract description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 4
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 4
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 4
- 239000000787 lecithin Substances 0.000 claims abstract description 4
- 229940067606 lecithin Drugs 0.000 claims abstract description 4
- 235000010445 lecithin Nutrition 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 239000011265 semifinished product Substances 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- 235000019722 synbiotics Nutrition 0.000 claims description 3
- 235000013350 formula milk Nutrition 0.000 claims 6
- 235000020610 powder formula Nutrition 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 10
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 3
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 230000000717 retained effect Effects 0.000 abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 abstract description 2
- 235000020254 sheep milk Nutrition 0.000 abstract 2
- 239000002131 composite material Substances 0.000 abstract 1
- 235000021048 nutrient requirements Nutrition 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108050000244 Alpha-s1 casein Proteins 0.000 description 1
- 102000009366 Alpha-s1 casein Human genes 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000021246 κ-casein Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a goat milk powder, in particular to a goat milk powder which is specially added with omega III, lactobacillus plantarum and the like and is formulated in a scientific proportion for middle-aged and elderly people, solves the problem of incomprehensive nutrition of the goat milk powder, and comprises the following raw materials and proportions: the three-component composite feed comprises 20 parts of omega three raw materials, 500 parts of raw sheep milk, 10 parts of prebiotics, 10 parts of sweetening agent, 200 parts of bifidobacterium bifidum freeze-dried powder, 300 parts of lactobacillus plantarum freeze-dried powder, 200 parts of skim milk powder, 50 parts of isomaltooligosaccharide, 30 parts of fructo-oligosaccharide, 20-60 parts of WPC34 whey protein powder, 20 parts of lecithin and 20 parts of lactobacillus casei, and ACE inhibitory peptide can be generated by adopting a fermentation process, so that the sheep milk powder is not only suitable for common people to eat, but also suitable for people with hypertension, hyperlipidemia, obesity and the like, the production process is not easy to destroy nutrient substances, the nutrient substances are retained to the maximum extent, and the feed also contains omega 3 and lactobacillus plantarum for multi-aspect nutrient supplement, and the diversified nutrient requirements are met.
Description
Technical Field
The invention relates to goat milk powder, in particular to scientific ratio formula goat milk powder specially added with omega III, lactobacillus plantarum and the like for middle-aged and elderly people.
Background
The goat milk is rich in nutrition, is rich in nutrients such as protein and minerals, and is easy to digest. The total content of protein, mineral and various vitamins is higher than that of cow milk, the size of fat globules is the same as that of human milk, and the fat globules are easy to be absorbed by human body, compared with cow milk, the digestibility of the goat milk for infants can reach more than 94%. The existing milk powder has single nutrient component and little effect, and can not meet the nutritional requirements of consumers. Meanwhile, the existing goat milk powder is mixed once, so that the nutritional ingredients of some components are easily damaged. Therefore, the production and development of the functional formula goat milk powder beneficial to human brain protection by taking goat milk as a base material are vital.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the scientific ratio formula goat milk powder specially added with omega III, lactobacillus plantarum and the like for middle-aged and elderly people.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows: the scientific ratio formula goat milk powder specially added with omega III, lactobacillus plantarum and the like for middle-aged and elderly people comprises the following raw materials and proportions: 20 parts of omega-three raw materials, 500 parts of raw goat milk, 10 parts of prebiotics, 10 parts of sweetening agent, 200 parts of bifidobacterium bifidum freeze-dried powder, 300 parts of lactobacillus plantarum freeze-dried powder, 200 parts of skim milk powder, 50 parts of isomaltooligosaccharide, 30 parts of fructo-oligosaccharide, 20-60 parts of WPC34 whey protein powder, 20 parts of lecithin and 20 parts of lactobacillus casei.
Preferably, the prebiotics are one or more of stachyose, galacto-oligosaccharide, isomalto-oligosaccharide, xylo-oligosaccharide and inulin.
Preferably, the sweetener comprises glucose.
Preferably, the raw materials form a fermentation type synbiotic defatted goat milk semi-finished product through secondary fermentation.
Preferably, the raw material also comprises an antioxidant.
Preferably, the viable count of the freeze-dried powder of the bifidobacterium bifidum is 1.0 multiplied by 1010-6.0 multiplied by 1010 cfu/g.
Preferably, the viable count of the lactobacillus plantarum freeze-dried powder is 1.0 multiplied by 1010-7.4 multiplied by 1010 cfu/g.
The invention has the beneficial effects that: the scientific proportion formula goat milk powder specially added with omega III, lactobacillus plantarum and the like provided by the invention can generate ACE inhibitory peptide by adopting a fermentation process, so that the goat milk powder is not only suitable for common people to eat, but also suitable for people suffering from hypertension, hyperlipidemia, obesity and the like, the production process is not easy to damage nutrient substances, the nutrient substances are retained to the maximum extent, and the goat milk powder also contains omega 3 and lactobacillus plantarum for nutrition supplement in various aspects, so that diversified nutritional requirements are met.
Drawings
FIG. 1 is a schematic diagram of the raw material ratio of the present invention.
Detailed Description
As shown in figure 1, the scientific ratio formula goat milk powder specially added with omega III, lactobacillus plantarum and the like for middle-aged and elderly people comprises the following raw materials in parts by weight: 20 parts of omega-three raw materials, 500 parts of raw goat milk, 10 parts of prebiotics, 10 parts of sweetening agent, 200 parts of bifidobacterium bifidum freeze-dried powder, 300 parts of lactobacillus plantarum freeze-dried powder, 200 parts of skim milk powder, 50 parts of isomaltooligosaccharide, 30 parts of fructo-oligosaccharide, 20-60 parts of WPC34 whey protein powder, 20 parts of lecithin and 20 parts of lactobacillus casei. The raw/full-fat goat milk powder is selected, so that the protein quality in the goat milk powder is extremely high, the goat milk powder contains components such as alpha-milk protein, beta-lactoglobulin, kappa-casein, alpha s 1-casein and the like, and galactose and lactose in the goat milk are easily absorbed and digested by a human body. Adding the skim milk powder, adjusting the protein component of the product, and satisfying the sufficient supplement of high-quality amino acid. The D90 desalted whey powder is selected to adjust the ash content in the finished goat milk powder, so that the nutrient substances required in the growth process of human bodies can be effectively supplemented, and the goat milk powder is beneficial to the health of human bodies. The WPC34 whey protein powder is selected to provide amino acids required by human body, delay aging of human body, regulate water and electrolyte balance in body, enhance anti-fatigue capability of organism, produce enzyme in body, improve gastrointestinal function and accelerate organism repair. The linseed oil is selected, so that the development of human brains can be promoted, brain transmission media can be increased, the brain activity function can be enhanced, the brain work is more effective, the thinking capability is better, and the intelligence is higher; can improve the functions of human intestines, promote absorption, increase the peristalsis ability of intestines and ensure normal defecation of human body; promoting vision development, improving eyesight acuity, receiving more visual stimulation, improving cognitive ability, facilitating retina development and being beneficial to vision health; enhancing immunity, benefiting physical function and body development, promoting physical growth, etc. Adding isomaltooligosaccharide which can not be absorbed by stomach and small intestine but directly enter large intestine to become bifidobacterium proliferation factor; other harmful bacteria in the intestines cannot be utilized, so that the growth of the harmful bacteria can be inhibited, the microecology in the intestines can be promoted to be adjusted to a benign cycle, the food has the characteristics of water-soluble dietary fiber function, low calorific value, caries prevention and the like, is not absorbed and utilized in the stomach, and completely enters the intestines, and can not increase the blood sugar or change the insulin level in the blood after being eaten for a long time, so that a diabetic patient can eat the food with confidence.
OMEGA-3, namely OMEGA-3, is also written as OMEGA-3, w-3 and n-3, and is called as OMEGA-3, OMEGA-3 and OMEGA-3 in Chinese, and is a group of polyunsaturated fatty acids which are commonly found in antarctic krill, deep-sea fish and some plants and are very beneficial to the health of human bodies.
The prebiotics are one or more of stachyose, galacto-oligosaccharide, isomalto-oligosaccharide, xylo-oligosaccharide and inulin. Prebiotics are such a substance: it is a dietary supplement that is a non-digestible food ingredient that beneficially affects the host by selectively stimulating the growth and activity of one or a small number of bacteria in the colony, thereby improving host health. Successful prebiotics should be largely undigested and fermented by the gut flora when passing through the upper gut. Most importantly, it stimulates the growth of beneficial bacterial flora and not harmful bacteria with potentially pathogenic or putrefactive activity.
The sweetener comprises glucose. Glucose plays an important role in the field of biology, and is an energy source and a metabolic intermediate product of living cells, namely a main energy supply substance of organisms.
The raw materials are fermented for the second time to form a semi-finished product of the fermented synbiotic defatted goat milk. Lactobacillus plantarum L69 ferments in goat milk to produce ACE inhibitory peptide, which can effectively reduce hypertension.
The raw materials also comprise an antioxidant, so that the storage life and the microbial activity of the product are improved.
The viable count of the freeze-dried powder of the bifidobacterium bifidum is 1.0 multiplied by 1010-6.0 multiplied by 1010 cfu/g. The viable count of the lactobacillus plantarum freeze-dried powder is 1.0 multiplied by 1010-7.4 multiplied by 1010 cfu/g. The survival rate of the fungus is high, and the nutrient substances can be absorbed and utilized by the human body.
The invention has the beneficial effects that: the scientific proportion formula goat milk powder specially added with omega III, lactobacillus plantarum and the like provided by the invention can generate ACE inhibitory peptide by adopting a fermentation process, so that the goat milk powder is not only suitable for common people to eat, but also suitable for people suffering from hypertension, hyperlipidemia, obesity and the like, the production process is not easy to damage nutrient substances, the nutrient substances are retained to the maximum extent, and the goat milk powder also contains omega 3 and lactobacillus plantarum for nutrition supplement in various aspects, so that diversified nutritional requirements are met.
In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate orientations or positional relationships based on those shown in the drawings, and are only for convenience in describing and simplifying the description, but do not indicate or imply that the devices or elements referred to must have a specific orientation, be constructed in a specific orientation, and be operated, and therefore, are not to be considered as limiting the present invention, and that the fundamental principles, the main features, and the advantages of the present invention are shown and described above, as would be understood by those skilled in the art.
Claims (7)
1. The scientific ratio formula goat milk powder specially added with omega III, lactobacillus plantarum and the like for middle-aged and elderly people is characterized by comprising the following raw materials in parts by weight: 20 parts of omega-three raw materials, 500 parts of raw goat milk, 10 parts of prebiotics, 10 parts of sweetening agent, 200 parts of bifidobacterium bifidum freeze-dried powder, 300 parts of lactobacillus plantarum freeze-dried powder, 200 parts of skim milk powder, 50 parts of isomaltooligosaccharide, 30 parts of fructo-oligosaccharide, 20-60 parts of WPC34 whey protein powder, 20 parts of lecithin and 20 parts of lactobacillus casei.
2. The scientific ratio formula goat milk powder specially added with omega three and lactobacillus plantarum and the like for middle-aged and elderly people according to claim 1, characterized in that the prebiotics are one or more of stachyose, galacto-oligosaccharide, isomalto-oligosaccharide, xylo-oligosaccharide and inulin.
3. The goat milk powder formula specially added with omega three and lactobacillus plantarum and other scientific proportions for middle aged and elderly people according to claim 1 or 2, wherein the sweetener comprises glucose.
4. The scientific ratio formula goat milk powder specially added with omega three and lactobacillus plantarum and the like for middle-aged and elderly people according to claim 3, characterized in that the raw material forms a fermented synbiotic defatted goat milk semi-finished product through secondary fermentation.
5. The scientific ratio formula goat milk powder specially added with omega three and lactobacillus plantarum and the like for middle aged and elderly people according to claim 4, characterized in that the raw materials further comprise an antioxidant.
6. The scientific ratio formula goat milk powder specially added with omega three and lactobacillus plantarum and the like for middle-aged and elderly people according to claim 1, wherein the viable count of the freeze-dried powder of bifidobacterium bifidum is 1.0 x 1010-6.0 x 1010 cfu/g.
7. The scientific ratio formula goat milk powder specially added with omega three and lactobacillus plantarum and the like for middle-aged and elderly people according to claim 1, characterized in that the viable count of the lactobacillus plantarum freeze-dried powder is 1.0 x 1010-7.4 x 1010 cfu/g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910781402.2A CN112400995A (en) | 2019-08-23 | 2019-08-23 | Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910781402.2A CN112400995A (en) | 2019-08-23 | 2019-08-23 | Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112400995A true CN112400995A (en) | 2021-02-26 |
Family
ID=74780369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910781402.2A Pending CN112400995A (en) | 2019-08-23 | 2019-08-23 | Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112400995A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810222A (en) * | 2010-04-23 | 2010-08-25 | 陕西农产品加工技术研究院 | Synbiotic goat milk powder |
| CN104824166A (en) * | 2015-05-08 | 2015-08-12 | 陕西雅泰乳业有限公司 | Cow/sheep milk powder containing lactobacillus and preparation method thereof |
| CN108782758A (en) * | 2018-06-22 | 2018-11-13 | 陕西师范大学 | A kind of fermented type synbiotic goat milk powder and preparation method thereof |
| CN109619191A (en) * | 2018-11-28 | 2019-04-16 | 陕西百跃优利士乳业有限公司 | Formula sheep milk powder rich in omega-3 polyunsaturated fatty acids and preparation method thereof |
-
2019
- 2019-08-23 CN CN201910781402.2A patent/CN112400995A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810222A (en) * | 2010-04-23 | 2010-08-25 | 陕西农产品加工技术研究院 | Synbiotic goat milk powder |
| CN104824166A (en) * | 2015-05-08 | 2015-08-12 | 陕西雅泰乳业有限公司 | Cow/sheep milk powder containing lactobacillus and preparation method thereof |
| CN108782758A (en) * | 2018-06-22 | 2018-11-13 | 陕西师范大学 | A kind of fermented type synbiotic goat milk powder and preparation method thereof |
| CN109619191A (en) * | 2018-11-28 | 2019-04-16 | 陕西百跃优利士乳业有限公司 | Formula sheep milk powder rich in omega-3 polyunsaturated fatty acids and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103764155B (en) | Promote the lactic acid bacteria of body movement | |
| US20040253227A1 (en) | Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery | |
| JPH088846B2 (en) | Nutrient composition and method for producing the same | |
| CN105025909A (en) | Anti-stress agent | |
| CN108244252A (en) | Probiotics multielement protein powder and preparation method thereof | |
| CN103564044A (en) | Alga-contained yoghourt and manufacturing method thereof | |
| CN101564133A (en) | Soybean yogurt and preparation method thereof | |
| KR20100027639A (en) | Nutrition balanced yogurt fermented from soy bean milk and milk by kimchi and milk lactic acid bacteria complex and a method of manufacture thereof | |
| RU2452243C2 (en) | Natural product containing probiotic microorganisms | |
| CN103271274A (en) | Nutrient health-care porridge | |
| CN112042766A (en) | Chitosan oligosaccharide probiotic yak milk polypeptide formula milk powder and preparation method thereof | |
| CN109548956A (en) | A kind of pet nutrition liquid and preparation method thereof | |
| CN100334226C (en) | Process and application for producing fermant protein peptide | |
| US20230227771A1 (en) | Pre-conditioning of l.reuteri | |
| CN106857821A (en) | Diet yogurt powder | |
| KR101106676B1 (en) | Animal and vegetable nutrition balance of fermented soy milk and milk with lactic acid bacteria, patient food and manufacturing method thereof | |
| CN108740335A (en) | A kind of formula of piglet feed | |
| CN104509915A (en) | Preparation method of tomato vinegar | |
| CN107259264A (en) | A kind of live lactobacillus sp beverage and preparation method thereof | |
| RU2426438C2 (en) | Synbiotic composition for correction of intestinal tract microbiocenosis abnormalities and enhancement of organism general resistivity and its production methods (versions) | |
| CN112400995A (en) | Scientific ratio formula goat milk powder specially added with omega III and lactobacillus plantarum and the like for middle-aged and elderly people | |
| CN106857822A (en) | Voluntarily fermented yoghourt powder | |
| CN106135427A (en) | Lactic acid bacteria, vegetable protein beverage formula | |
| CN108432879A (en) | A kind of complex function Sourbean milk that can remove beany flavor | |
| CN103555801A (en) | Method for preparing polypeptide through lactobacillus solid-state fermentation enzymolysis of bean pulps |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210226 |
|
| RJ01 | Rejection of invention patent application after publication |